Integra LifeSciences Holdings CorporationIARTNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank7
3Y CAGR-23.4%
5Y CAGR-19.1%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
-23.4%/yr
vs +2.7%/yr prior
5Y CAGR
-19.1%/yr
Recent deceleration
Acceleration
-26.1pp
Decelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.3x
Contraction
Streak
5 yr
Consecutive declineCompressed
PeriodValueYoY Change
20251.68-22.2%
20242.16-30.6%
20233.12-16.6%
20223.74-15.5%
20214.43-9.1%
20204.87+18.2%
20194.12+22.5%
20183.36-26.2%
20174.56+20.1%
20163.80-